Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Marlin Global (MLN) / FY23

Portfolio swung to NZ$27.6m total return but NTA stayed near lower edge

NPAT rebounded to NZ$23.6m and NTA per share rose 4.5% to NZ$0.93, yet net assets of NZ$192.8m remain at the lower edge of Marlin's recent range.

Investment Companies / Listed investment company

NTA/NAV per share

Net tangible asset or net asset value per share, shown in per-share cents for chart readability.

↗
Loading chart...
  • HY22 MLN: Unprecedented high nta/nav per share. 1.26x; 4-period range 0.8x to 1.02x. NTA/NAV per share: 1.26x, unprecedented high; 4-period mean 0.93x, range 0.80x-1.02x.
  • FY22 MLN: Outside range low nta/nav per share. 0.89x; 4-period range 0.93x to 30x. NTA/NAV per share: 0.89x, below normal range; 4-period mean 8.31x, range 0.93x-30.00x.
  • HY23 MLN: Outside range low nta/nav per share. 0.8x; 4-period range 0.94x to 1.26x. NTA/NAV per share: 0.80x, below normal range; 4-period mean 1.04x, range 0.94x-1.26x.
NTA/NAV per share: 0.80x, below normal range; 4-period mean 1.04x, range 0.94x-1.26x.

Investment income

Recurring investment-income or revenue-return proxy, excluding fair-value movement where disclosed.

↗
Loading chart...
  • FY21 MLN: Outside range low investment income. $0.6m; 4-period range $0.7m to $1.2m. Investment income: NZ$0.6m, below normal range; 4-period mean NZ$1.0m, range NZ$0.7m-NZ$1.2m.
  • HY22 MLN: Outside range low investment income. $0.2m; 4-period range $0.3m to $0.9m. Investment income: NZ$0.2m, below normal range; 4-period mean NZ$0.5m, range NZ$0.3m-NZ$0.9m.
Investment income: NZ$0.2m, below normal range; 4-period mean NZ$0.5m, range NZ$0.3m-NZ$0.9m.

Investment total return

Total income or return including fair-value or capital movement where disclosed.

↗
Loading chart...
  • FY21 MLN: Outside range high investment total return. $78.1m; 4-period range $-58.5m to $42.9m. Investment total return: NZ$78.1m, above normal range; 4-period mean NZ$4.5m, range NZ$-58.5m-NZ$42.9m.
  • FY22 MLN: Unprecedented low investment total return. $-58.5m; 4-period range $5.9m to $78.1m. Investment total return: NZ$-58.5m, unprecedented low; 4-period mean NZ$38.6m, range NZ$5.9m-NZ$78.1m.
  • HY23 MLN: Unprecedented low investment total return. $-9.4m; 4-period range $6.3m to $12.4m. Investment total return: NZ$-9.4m, unprecedented low; 4-period mean NZ$9.8m, range NZ$6.3m-NZ$12.4m.
Investment total return: NZ$-9.4m, unprecedented low; 4-period mean NZ$9.8m, range NZ$6.3m-NZ$12.4m.

Net assets attributable

Net asset base attributable to shareholders or unitholders.

↗
Loading chart...
  • FY21 MLN: Unprecedented high net assets attributable. $244.4m; 4-period range $178.1m to $222.9m. Net assets attributable: NZ$244.4m, unprecedented high; 4-period mean NZ$201.5m, range NZ$178.1m-NZ$222.9m.
  • HY22 MLN: Outside range high net assets attributable. $242.1m; 4-period range $161.9m to $224.7m. Net assets attributable: NZ$242.1m, above normal range; 4-period mean NZ$200.4m, range NZ$161.9m-NZ$224.7m.
  • FY22 MLN: Unprecedented low net assets attributable. $178.1m; 4-period range $192.8m to $244.4m. Net assets attributable: NZ$178.1m, unprecedented low; 4-period mean NZ$218.0m, range NZ$192.8m-NZ$244.4m.
  • HY23 MLN: Unprecedented low net assets attributable. $161.9m; 4-period range $201.6m to $242.1m. Net assets attributable: NZ$161.9m, unprecedented low; 4-period mean NZ$220.4m, range NZ$201.6m-NZ$242.1m.
Net assets attributable: NZ$161.9m, unprecedented low; 4-period mean NZ$220.4m, range NZ$201.6m-NZ$242.1m.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 8 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$181.2m

i

End-of-day close multiplied by current shares on issue.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

9.3%

i

Trailing dividends compared with the latest close.

Premium / discount

-15.8%

i

For investment companies, price compared with reported NTA.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not meaningful when recent earnings are negative.

EPS

-0.01

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not meaningful without positive comparable earnings growth.

EV/EBITDA

Not available

i

Not useful for this reporting shape.

P/FCF

Not available

i

Not available for this company right now.

Release date
22 August 2023
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

FY23 vs FY22

Net profit after tax

$23.6m

+139.1% ↑ vs −$60.4m

Net cash inflow from operating activities

$22.6m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Full-year dividend per share

3.5c

+88.1% ↑ vs 1.9c

Investment income

$0.76m

+15.8% ↑ vs $0.66m

Profit before tax

$24.4m

+139.9% ↑ vs −$61.2m

Cash and cash equivalents

$16.2m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Total assets

$202.4m

+12.2% ↑ vs $180.3m

What changed

Marlin's portfolio total return swung to +NZ$27.6m from -NZ$58.5m in FY22, lifting NPAT to NZ$23.6m from -NZ$60.4m and ROE to 12.2% from -33.9%

Investment income (dividend and interest) rose 15.8% to NZ$0.8m, equal to the supplied historical mean.

NTA per share recovered to NZ$0.93 from NZ$0.89 (+4.5%) and net assets attributable grew 8.2% to NZ$192.8m. Both remain at the lower edge of Marlin's recent historical range — net assets sit NZ$18.7m below the three-period mean of NZ$211.5m. The benchmark total return of 15.3% was also at the lower edge of its historical range (mean 29.5%).

What matters

The rebound is real but only partial

A NZ$27.6m total return reverses most of FY22's NZ$58.5m loss in dollar terms, but net assets attributable of NZ$192.8m and NTA per share of NZ$0.93 both sit at the lower edge of the supplied historical range. For shareholders, that means equity has not yet been rebuilt to its recent baseline despite a strong recovery year.

Distributions are capital-funded, not income-funded. Recurring investment income of NZ$0.8m covered only 8.6% of the NZ$8.9m distributions paid during the year. Future distribution capacity therefore depends on portfolio total returns continuing rather than a stable dividend/interest income stream, which matters in periods when fair-value movements turn negative.

Recovery occurred against a moderate market backdrop. The 15.3% benchmark return is at the lower edge of the supplied historical range (mean 29.5%), so Marlin rebounded into a moderate market, not a strong one. The release does not disclose portfolio total return percent or a benchmark-relative outperformance figure, leaving the active-management read unresolved.

Expectations

The interim period (HY23) showed an NPAT loss of NZ$11.6m, meaning the second half delivered an implied +NZ$35.2m swing

This was a market-recovery-led pattern rather than a steady-state run-rate, so the full-year shape should not be annualised forward.

No forward targets, NTA guidance, expense-ratio commitment, or benchmark-relative outperformance objective are supplied. The release declares a final dividend component of 1.82 cents per share, taking the full-year distribution to 3.48 cents per share; there is no equivalent prior-year full-year figure in the supplied data and no guidance on next-year distribution policy. The gap matters because investors lack forward visibility on positioning, costs, or distribution cadence.

Quality of result

Most of the FY23 result is portfolio total return — fair-value and realised investment gains — rather than recurring investment income

Dividend and interest receipts of NZ$0.8m are genuinely recurring and match the historical mean, but they represent only about 3% of the NZ$27.6m total return. The result is therefore market-dependent: the same portfolio in a flat or down market would produce a loss profile similar to FY22.

Operating cash inflow of NZ$22.6m (vs NZ$3.4m prior) reflects net investment realisations and dividend collection — not operating cash conversion in the conventional sense, and not an indication of recurring earning power. The effective tax rate of 3.3% is within Marlin's historical range, and PBT and NPAT growth tracked each other (+139.8% vs +139.1%, a 0.7 percentage-point gap), so there is no tax-driven distortion to unwind. ROE of 12.2% sits above the historical mean of -1.8% but the comparison is dominated by portfolio fair-value movement rather than persistent return generation.

Unresolved

Open questions

What drove the second-half portfolio recovery — stock-specific decisions or broader market beta lifting positions?
How did portfolio total return compare to the 15.3% benchmark, given the release does not disclose a portfolio-percent or active-return figure?
Why does NTA per share remain at the lower edge of the historical range despite a positive NZ$27.6m total return, and what closes that gap?
How sustainable is the current distribution rate when investment income covers only 8.6% of distributions paid?
What is the expense ratio and how has it moved across the recovery period?

This briefing cannot assess portfolio-relative performance versus the benchmark, the sustainability of the distribution rate beyond the announced final component, or management's forward positioning intent given the absence of disclosed targets and active-return metrics.

Chat

Ask about MLN FY23

Ask follow-up questions about Marlin Global's FY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about MLN FY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Marlin Global's FY23 result.

What drove the second-half portfolio recovery — stock-specific decisions or broader market beta lifting positions?Why does "The rebound is real but only partial" matter?How strong was the cash and earnings quality in FY23?What should I watch next for MLN after FY23?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Marlin Global 2023 Annual Report

FY23 / financial report↗

Prior comparable period

Marlin Global 2022 Annual Report

FY22 / financial report↗

Interim context

MLN - Commentary for the interim period 2023

HY23 / results release↗

MLN - Interim financial statements for period 31 Dec 2022 incl review report

HY23 / financial report↗

MLN - Preliminary half year announcement 31 Dec 2022

HY23 / results announcement↗

Related insights

Cross-company views selected from the metrics in this briefing.

ROE and capital efficiency

ROE was 12.2%, +46.1pp versus the prior comparable period.

→

Revenue growth context

Revenue growth was 15.8% for this reporting period.

→

Dividend coverage and payout pressure

Dividend payout versus NPAT is 29.9%.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 0.7pp.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when MLN publishes next

Get the next Marlin Global briefing and related NZX reporting-season updates by email.